Pluristem Appoints Dr. Edwin Horwitz to Scientific Advisory Board

Pluristem Life Systems, Inc. has announced that Edwin M Horwitz, M.D., PhD. has joined the Company's Scientific Advisory Board.

Professor Horwitz is a pioneer and world-renowned leader in the clinical use of stem cells. He is recognized for his work on the transplantation of pre-selected hematopoietic stem cells and for his contribution to the field of mesenchymal cell therapy.

Professor Horwitz is the recipient and principal investigator of multiple NIH and other grants in the field of mesenchymal cell therapy.

Nature Medicine published his first work, addressing use of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta, in 1999.

Professor Horwitz is the chairman of the Mesenchymal Stem Cell scientific committee of the International Society of Cellular Therapy (ISCT) and co-chair of the committee on gene marking of the Center for International Blood and Marrow Transplant Research.